Tesetaxel Every 3 Weeks vs Weekly vs Capecitabine as 1st-line Therapy for Locally Advanced or Metastatic Breast Cancer

NCT01609127 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

213

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced Non-resectable Breast Cancer
Metastatic Breast Cancer

Interventions

DRUG: Tesetaxel
DRUG: Tesetaxel
DRUG: Capecitabine

Sponsor

Genta Incorporated